Stanton C J
Department of Surgery, Sacred Heart Medical Center, 1255 Hilyard Street, Eugene, OR 97401, USA.
Surg Endosc. 1999 Nov;13(11):1083-6. doi: 10.1007/s004649901178.
Laparoscopic splenectomy (LS) has rapidly become the preferred surgical treatment for idiopathic thrombocytopenic purpura (ITP), but its long-term efficacy for this disorder is unproved. This report documents the author's 5-year experience with, and long-term follow-up of, LS for ITP.
Between September 1992 and September 1997, 30 patients with clinical ITP and intractable thrombocytopenia were referred as surgical candidates. Two of them (7%) were converted to open, and the other 28 underwent successful LS. The operative approach evolved from a supine lithotomy to right lateral decubitus position, and the harmonic scalpel became the primary dissection tool in the later part of the study.
The 28 successful LS patients constituted the study group. Accessory spleens were identified and resected in six patients (21%). Surgical times and blood loss averaged 2.4 h and 170 cc, respectively. The typical hospital stay was 2 days. Initial reversal of thrombocytopenia and ultimate cessation of oral steroids was achieved in 25 of 28 patients (89%). There were no deaths, but two patients had major complications (bleeding and pneumonia). All but two patients experienced a return to full activity and/or employment by 3 weeks post-LS. In the three cases that failed LS, none had residual splenic tissue on subsequent radionuclide scan. Long-term follow-up (2-60 months) was obtained in 22 of 28 patients (79%). The only death (at 13 months) resulted from oncologic disease. Twenty-one patients had lasting clinical remission of ITP. A positive preoperative response to oral steroids was the best predictor of success.
This 5-year experience with LS supports its use for the surgical treatment of ITP. The procedure is safe and efficacious, resulting in brief hospitalization, minimal recovery time, and excellent long-term results.
腹腔镜脾切除术(LS)已迅速成为特发性血小板减少性紫癜(ITP)的首选手术治疗方法,但其对该疾病的长期疗效尚未得到证实。本报告记录了作者对ITP患者行LS的5年经验及长期随访情况。
1992年9月至1997年9月,30例临床诊断为ITP且血小板减少难治的患者被推荐为手术候选人。其中2例(7%)转为开放手术,另外28例成功接受了LS。手术入路从仰卧位截石位演变为右侧卧位,在研究后期,超声刀成为主要的解剖工具。
28例成功接受LS的患者构成研究组。6例患者(21%)发现并切除了副脾。手术时间和失血量平均分别为2.4小时和170毫升。典型的住院时间为2天。28例患者中有25例(89%)血小板减少症最初得到缓解,最终停用了口服类固醇。无死亡病例,但有2例患者出现严重并发症(出血和肺炎)。除2例患者外,所有患者在LS术后3周恢复了全部活动和/或工作。在3例LS失败的病例中,后续放射性核素扫描均未发现残留脾组织。28例患者中有22例(79%)获得了长期随访(2 - 60个月)。唯一的死亡病例(13个月时)死于肿瘤疾病。21例患者ITP获得持久临床缓解。术前对口服类固醇有阳性反应是成功的最佳预测指标。
这5年的LS经验支持其用于ITP的手术治疗。该手术安全有效,住院时间短,恢复时间短,长期效果良好。